Latest CYCN reports update at 2024-05-07: 2024-Q12023-Q42023-Q1
Cyclerion Therapeutics logo
Cyclerion Therapeutics CYCN
$ 2.72 28.7%

Cyclerion Therapeutics Operating Cash Flow 2011-2024 | CYCN

Annual Operating Cash Flow Cyclerion Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-21.2 M -40.6 M -36.5 M -72.5 M -102 M -97.5 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-21.2 M -102 M -61.8 M

Quarterly Operating Cash Flow Cyclerion Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-1.87 M - - - -6.21 M - -33.6 M -23.7 M -12.8 M - -27.9 M -20 M -14.5 M - -58.4 M -43.4 M -29.2 M - -80.1 M -56.2 M -34.3 M - -74.4 M -49 M -26.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-1.87 M -80.1 M -34.8 M